Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00026774
DRKS00026774
Recruiting
Not Applicable

Influence of chronic Pseudomonas aeruginosa infection on airway inflammation during respiratory viral infections in adults with cystic fibrosis (CHRONOVIR) - CHRONOVIR

niversitätsklinikum Frankfurt am Main0 sites30 target enrollmentOctober 19, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsE84Cystic fibrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
E84
Sponsor
niversitätsklinikum Frankfurt am Main
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Frankfurt am Main

Eligibility Criteria

Inclusion Criteria

  • •Age \= 18 years.
  • •\- Confirmed diagnosis of CF by genetic testing.
  • •\- Regular patient of the Christiane Herzog CF Center Frankfurt with data from at least two routine check\-ups and one annual check\-up in the 12 months prior to inclusion in the study.
  • •\- PA free OR chronic pulmonary infection with PA.
  • •\- Written informed consent.

Exclusion Criteria

  • •\- Z.n. lung transplantation.
  • •\- Life expectancy \< 6 months or listed for lung transplantation.
  • •\- Systemic steroid therapy.
  • •\- Intravenous antibiotic therapy in the last 4 weeks.
  • •\- Last pulmonary infection exacerbation (clinical definition: indication for anti\-infective therapy (oral/intravenous).
  • •\- Intermittent PA infection
  • •\- Other chronic disease or infection with pulmonary infection not associated with CF (such as tuberculosis, lung carcinoma).
  • •\- Pregnancy
  • •\- Known alcohol or drug abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Influence of Pseudomonas aeruginosa colonisation status on respiratory muscle function in adult Cystic Fibrosis patientscystic fibrosisE84.0Cystic fibrosis with pulmonary manifestations
DRKS00008786Klinken der Stadt Köln gGmbhLungenklinik Merheim51
Completed
Not Applicable
Respiratory infections with Pseudomonas aeruginosa in children with Cystic Fibrosis; early surveillance and preventioPulmonary P. aeruginosa infection, cystic fibrosisNutritional, Metabolic, EndocrineCystic fibrosis
ISRCTN11604593niversity Medical Center Utrecht (UMCU) (The Netherlands)100
Recruiting
Not Applicable
Airway colonization with Pseudomonas aeruginosa in chronic obstructive pulmonary disease (COPD)/non-CF bronchiectasis - an observational and biomaterial studyJ44.9J47B96.5Chronic obstructive pulmonary disease, unspecifiedBronchiectasisPseudomonas (aeruginosa) as the cause of diseases classified to other chapters
DRKS00023975ungenClinic Grosshansdorf80
Completed
Not Applicable
Transmission of Pseudomonas aeruginosa during an open air event for Cystic Fibrosis patientsCystic Fibrosismucoviscidosis100836241000401810024450
NL-OMON33900niversitair Medisch Centrum Utrecht50
Active, not recruiting
Phase 1
Clinical study to assess two different Pseudomonas aeruginosa eradication protocols in patients with cystic ¿brosiscystic fibrosisMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2015-003881-96-ITAZIENDA OSPEDALIERO-UNIVERSITARIA MEYER112